MHC Class I Expression on Red Blood Cells
Yes, MHC class I is absent on mature human red blood cells (RBCs). This is a fundamental characteristic that distinguishes mature erythrocytes from nearly all other nucleated somatic cells in the body.
The Evidence
The most recent and authoritative guideline evidence clearly establishes that MHC class I molecules are expressed in nearly all nucleated somatic cells 1. The critical distinction here is that mature human RBCs are anucleated - they lack a nucleus after maturation - and consequently do not express MHC class I molecules on their surface.
This absence is explicitly stated in the 2023 Nature Protocols guideline: "MHC class I molecules are expressed in nearly all nucleated somatic cells and present self- or cytosolic pathogens to CD8 T cells" 1. The emphasis on "nucleated" cells is deliberate and excludes mature RBCs, which have extruded their nuclei during the final stages of erythropoiesis.
Clinical Implications
Why This Matters
- Immune surveillance: The absence of MHC class I means mature RBCs cannot present antigens to CD8+ T cells, making them immunologically "invisible" in terms of classical antigen presentation
- Transfusion medicine: RBC transfusion reactions focus on ABO and Rh antigens, not MHC compatibility, precisely because mature RBCs lack MHC class I expression 2, 3
- Evolutionary advantage: This absence may protect RBCs from immune-mediated destruction during their 120-day lifespan in circulation
Important Caveats
Recent research has explored artificially conjugating MHC class I molecules to RBCs for therapeutic purposes. A 2024 study demonstrated that erythrocytes can be engineered with MHC-I fusion proteins (MHC-I‒Ery) to activate antigen-specific CD8+ T cells for cancer immunotherapy 4. However, this is an experimental modification - it does not reflect the natural state of mature human RBCs.
Additionally, nucleated RBCs in other species (such as teleost fish) do express MHC molecules and can function in antigen presentation 5. This is fundamentally different from mammalian physiology, where RBCs lose their nuclei and MHC expression during maturation.
The Bottom Line
In clinical practice, when considering human mature RBCs:
- No MHC class I expression on the cell surface
- No antigen presentation capability via classical MHC pathways
- Transfusion compatibility determined by blood group antigens (ABO, Rh), not MHC matching
- Any reported MHC expression on RBCs represents either immature reticulocytes, experimental modifications, or non-mammalian species